- Potential benefitMay increase public awareness leading more people to seek evaluation for cardiac symptoms.
- FamiliesCould raise diagnoses of HCM through greater provider screening and family history assessments.
- Potential benefitLikely increases demand for diagnostic services like echocardiograms, cardiac MRI, and genetic counseling.
Expressing support for the designation of the fourth Wednesday of February as "Hypertrophic Cardiomyopathy Awareness Day".
Referred to the House Committee on Energy and Commerce.
This resolution expresses the House's support for designating the fourth Wednesday of February as Hypertrophic Cardiomyopathy Awareness Day. It is a non-binding statement from the House that encourages awareness and urges Americans to seek appropriate care; it does not create new law or require action by other branches of government. As a simple House resolution, it reflects only the position of the House and has no legal force beyond that expression.
This simple House resolution expresses support for designating the fourth Wednesday of February as “Hypertrophic Cardiomyopathy Awareness Day.” It summarizes HCM prevalence, risks, diagnostic methods, and urges increased public awareness and appropriate care.
The resolution is symbolic and non‑binding.
Nonbinding House resolution with no statutory changes; even if adopted by the House it does not create law and would need separate Senate action to have legal force.
Relative to its intended legislative type, this bill functions as a straightforward commemorative resolution: it clearly states the condition being highlighted, specifies the observance date, and urges awareness and care-seeking. Its structure and level of detail are consistent with typical symbolic designations.
Liberals emphasize equity and linking awareness to services
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenResolution is symbolic and creates no funding, mandates, or enforceable programs.
- Potential burdenCould increase short-term healthcare utilization and associated costs due to more testing.
- Potential burdenExpanded screening risks overdiagnosis and potentially unnecessary follow-up procedures.
Why the argument around this bill splits.
Liberals emphasize equity and linking awareness to services
Likely broadly supportive because the resolution promotes health equity, early diagnosis, and family screening for an inheritable disease.
They will see awareness as a low‑cost, beneficial step toward reducing undiagnosed cases and preventing avoidable deaths.
Generally favorable: the resolution is a low‑cost, nonbinding awareness measure that addresses a clear public health issue.
They will look for practical follow‑through, measurable outcomes, and minimal unintended costs.
Probably supportive but mildly skeptical: the resolution is symbolic and nonbinding, so it avoids mandates or spending.
Some conservatives may question federal involvement in designating awareness days.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Nonbinding House resolution with no statutory changes; even if adopted by the House it does not create law and would need separate Senate action to have legal force.
- Whether a companion Senate resolution will be introduced
- Whether committee will report it to the floor
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals emphasize equity and linking awareness to services
Nonbinding House resolution with no statutory changes; even if adopted by the House it does not create law and would need separate Senate a…
Relative to its intended legislative type, this bill functions as a straightforward commemorative resolution: it clearly states the condition being highlighted, specifies the observance date, and urges awareness and car…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.